The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

30 Jan 2017 07:02

RNS Number : 4128V
Falanx Group Limited
30 January 2017
 

Falanx Group Limited

("Falanx" or "the Company")

 

DIRECTORATE CHANGE

 

Falanx Group (AIM:FLX), the global intelligence, security and cyber defence provider, is pleased to announce the appointment of Jay Abbott as Executive Director; Cyber Defence and main board Director of Falanx Group, with immediate effect. Mr Abbott holds an interest in Falanx Group of 7,125,536 Ordinary Shares, representing 5.67 per cent of the Company's issued share capital.

 

Appointment of Jay Abbott

 

The board of Falanx Group are delighted that Jay has accepted the offer to join the board of Falanx Group. His leadership and innovation in the field of Cyber Security is well known, having led the UK National Threat & Vulnerability Management Practice of PriceWaterhouseCoopers, before founding the extremely well regarded Cyber Security consultancy, ASC Ltd.

 

Jay is a celebrated key-note speaker who is regularly quoted in the media on the subject of Cyber Security. Over the past 20 years within the industry, Jay has spoken at high profile public and private events on the topics of cyber and information security.

 

His work and thought leadership with the UK Cyber Security Challenge, alongside some of the biggest names within commercial Cyber market and Government, has developed creative solutions to solving the skills shortage in the cyber industry. These innovations include the development of the "PoD online gaming platform" and the "Cyphinx - Immersive 3D Gaming platform", each an innovation in engaging the next generation of talent to ensure the future of the industry and protect the interest of the country.

 

Jay will continue in his role as the Managing Director of Falanx Cyber Defence while also defining the technology roadmap and innovation.

 

 

Mike Read, Chairman of Falanx Group, commented:

 

"Jay has led a remarkable Cyber development program and driven excellent revenue growth since he joined the group in May 2016. With this in mind and the new ground he and his team are breaking in the development of innovative new products and services, we are delighted that he has accepted our invitation to join the Board of Falanx Group and help shape the future of the company"

 

 

 

Additional information: disclosures required pursuant to Rule 17 and Schedule 2(g) of the AIM Rules for Companies ("AIM Rules")

 

Jay David Abbott, aged 40, is currently a director of Jabawok Industries Limited, Justasc Limited and Falanx Cyber Defence Limited.

 

There are no further disclosures to be made in accordance with Rule 17 and Schedule Two paragraph (g) of the AIM Rules.

 

 

 

Enquiries:

 

Falanx Group Limited

Stuart Bladen, Chief Executive Officer

 

 

www.falanxgroup.com

www.falanxassuria.com

www.falanxcyberdefence.com

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis / James Keeshan

 

+44 (0) 203 368 3551

 

Whitman Howard Limited

Broker

Nick Lovering / Francis North

 

+44 (0) 207 659 1234

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGUBGGUPMGAB
Date   Source Headline
9th Dec 20222:42 pmRNSHolding(s) in Company
8th Dec 20224:29 pmRNSResult of AGM
8th Dec 20227:00 amRNSInterim Results
24th Nov 20225:17 pmRNSHolding(s) in Company
15th Nov 20225:56 pmRNSNotice of AGM
18th Oct 20227:00 amRNSDirectorate Change
29th Sep 20227:00 amRNSFinal Results
20th Sep 20227:00 amRNSHolding(s) in Company
5th Sep 20224:53 pmRNSHolding(s) in Company
4th Aug 20222:06 pmRNSSecond Price Monitoring Extn
4th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 202211:05 amRNSSecond Price Monitoring Extn
4th Aug 202211:00 amRNSPrice Monitoring Extension
4th Aug 20227:00 amRNSTrading Update
9th May 20227:00 amRNSPartnership to Provide M-EDR to UK Customers
8th Apr 20224:06 pmRNSHolding(s) in Company
6th Apr 202211:59 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSChange of Adviser
30th Mar 20222:44 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:59 pmRNSDirector/PDMR Shareholding
10th Feb 202211:11 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20225:20 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 202111:14 amRNSResult of AGM
7th Dec 20217:00 amRNSInterim Results
16th Nov 20212:10 pmRNSNotice of AGM
29th Oct 20211:57 pmRNSExercise of Options, TVR and PDMR dealing
27th Oct 20219:03 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSDirector/PDMR Shareholding
25th Oct 20213:25 pmRNSExercise of Options and TVR
13th Oct 202111:06 amRNSSecond Price Monitoring Extn
13th Oct 202111:00 amRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSTrading update and BOOST&Co loan facility update
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20212:43 pmRNSSale of Assynt for £4.6 million
4th Oct 20217:00 amRNSFalanx Launch Mass Market Security Assessment Tool
29th Sep 20217:00 amRNSAnnual results for the year ended 31 March 2021
18th Aug 20217:01 amRNSGrant of share options
18th Aug 20217:00 amRNSTrading Update & New Loan Facility
9th Jul 20219:07 amRNSHolding(s) in Company
29th Apr 20217:00 amRNSCancellation of unapproved Share Options
1st Apr 20217:00 amRNSIssue of Equity and TVR
26th Feb 20213:31 pmRNSResult of GM
10th Feb 20212:03 pmRNSPublication of Circular & Notice of GM
8th Feb 202111:05 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSContract Wins and Covid Business Interruption Loan
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.